About Global Markets Direct

Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information.

With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.



  • Alzheimer's Disease - Pipeline Review, H1 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Directs, Alzheimer's Disease - Pipeline Review, H1 2014, provides an overview of the Alzheimer's Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alzheimer's Disea

  • Rheumatoid Arthritis - Pipeline Review, H1 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Rheumatoid Arthritis - Pipeline Review, H1 2014 Summary Global Markets Directs, Rheumatoid Arthritis - Pipeline Review, H1 2014, provides an overview of the Rheumatoid Arthritiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Rheumatoid Art

  • Type 2 Diabetes - Pipeline Review, H1 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Type 2 Diabetes - Pipeline Review, H1 2014 Summary Global Markets Directs, Type 2 Diabetes - Pipeline Review, H1 2014, provides an overview of the Type 2 Diabetess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete wit

  • Parkinson's Disease - Pipeline Review, H1 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Parkinson's Disease - Pipeline Review, H1 2014 Summary Global Markets Directs, Parkinson's Disease - Pipeline Review, H1 2014, provides an overview of the Parkinson's Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Parkinson's Disea

  • Hepatitis C - Pipeline Review, H1 2014


    $$2,500
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Hepatitis C - Pipeline Review, H1 2014 Summary Global Markets Directs, Hepatitis C - Pipeline Review, H1 2014, provides an overview of the Hepatitis Cs therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative an

  • Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014 Summary Global Markets Directs, Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD)s therapeutic pipeline. This report provides com

  • Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Directs, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)s

  • Neuropathic Pain - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Neuropathic Pain - Pipeline Review, H1 2014 Summary Global Markets Directs, Neuropathic Pain - Pipeline Review, H1 2014, provides an overview of the Neuropathic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Neuropathic Pain, complete

  • Colon Cancer - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Directs, Colon Cancer - Pipeline Review, H1 2014, provides an overview of the Colon Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colon Cancer, complete with comparativ

  • Psoriasis - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Directs, Psoriasis - Pipeline Review, H1 2014, provides an overview of the Psoriasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis a

  • Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014 Summary Global Markets Directs, Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2014, provides an overview of the Amyotrophic Lateral Sclerosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic dev

  • Schizophrenia - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Schizophrenia - Pipeline Review, H1 2014 Summary Global Markets Directs, Schizophrenia - Pipeline Review, H1 2014, provides an overview of the Schizophrenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Schizophrenia, complete with compar

  • Tuberculosis - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Tuberculosis - Pipeline Review, H1 2014 Summary Global Markets Directs, Tuberculosis - Pipeline Review, H1 2014, provides an overview of the Tuberculosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tuberculosis, complete with comparativ

  • Stroke - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Stroke - Pipeline Review, H1 2014 Summary Global Markets Directs, Stroke - Pipeline Review, H1 2014, provides an overview of the Strokes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative analysis at various st

  • HIV-1 Infection - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    HIV-1 Infection - Pipeline Review, H1 2014 Summary Global Markets Directs, HIV-1 Infection - Pipeline Review, H1 2014, provides an overview of the HIV-1 Infections therapeutic pipeline. This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete wit

  • Atherosclerosis - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Atherosclerosis - Pipeline Review, H1 2014 Summary Global Markets Directs, Atherosclerosis - Pipeline Review, H1 2014, provides an overview of the Atherosclerosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atherosclerosis, complete wit

  • Crohn's Disease - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Crohn's Disease - Pipeline Review, H1 2014 Summary Global Markets Directs, Crohn's Disease - Pipeline Review, H1 2014, provides an overview of the Crohn's Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Crohn's Disease, complete wit

  • Non-Hodgkin Lymphoma - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Directs, Non-Hodgkin Lymphoma - Pipeline Review, H1 2014, provides an overview of the Non-Hodgkin Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Hodgkin Ly

  • Myocardial Infarction - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Myocardial Infarction - Pipeline Review, H1 2014 Summary Global Markets Directs, Myocardial Infarction - Pipeline Review, H1 2014, provides an overview of the Myocardial Infarctions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial

  • Ulcerative Colitis - Pipeline Review, H1 2014


    $$2,000
    2014-02-28 00:00:00 | Published by: Global Markets Direct

    Ulcerative Colitis - Pipeline Review, H1 2014 Summary Global Markets Directs, Ulcerative Colitis - Pipeline Review, H1 2014, provides an overview of the Ulcerative Colitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ulcerative Colitis,



 1 2 3 >  Last ›